We report herein mutations of ATP2C1 in 11 Japanese patients with Hailey±Hailey disease gene (including ®ve previously reported) and compare the mutation pattern with clinical phenotypes. Patients with missense mutations and some of those with mutations causing premature termination showed erythema and erosions primarily at intertriginous areas. In two families with unique mutations, one with an in-frame three amino acid deletion plus an eight amino acid insertion and one with a two base pair deletion predicted to cause premature truncation, some affected individuals had unique clinical features ± generalization of Hailey±Hailey disease and generalized skin eruption resembling keratotic papules in Darier's disease ± but other affected individuals did not, suggesting the presence of severe intrafamilial phenotype variations. Our ®ndings suggest that differences in clinical phenotypes are probably related to factors other than the type of causative mutation. Key words: ATP2C1/ Hailey±Hailey disease/mutations/phenotype. J Invest Dermatol 117: 1654±1656, 2001 H ailey±Hailey disease (HHD; McKusick no. 16960) is an autosomal dominant inherited skin disease characterized by recurrent blistering predominantly at intertriginous areas. Lesions usually appear after puberty and continue throughout life with only uncommon long-term remission (Burge, 1992) . Occasional patients have clinical variants such as generalization or lesions of predominantly verrucous appearance (Burge, 1992; Ikeda et al, submitted) .
The gene whose mutations underlie HHD was mapped to the long arm of chromosome 3 and so far no locus heterogeneity has been reported (Ikeda et al, 1994; Peluso et al, 1995; Richard et al, 1995) . Two independent groups recently identi®ed HHD-causing mutations in ATP2C1, a homolog of a yeast Ca 2+ ATPase that pumps Ca 2+ from the cytosol to the Golgi (Hu et al, 2000; Sudbrak et al, 2000) . In this study, we identi®ed additional mutations of this gene by conformation sensitive gel electrophoresis (CSGE) analysis and direct sequencing of genomic DNA from six Japanese families and solitary patients with HHD. By including our ®ve previously described Japanese patients with ATP2C1 mutations (Hu et al, 2000) , we are able to compare genotype and phenotype in a reasonably large group of patients of relatively homogeneous genetic background.
MATERIALS AND METHODS
Diagnosis of the disease was made primarily by clinical features and medical history. At least one affected individual from each family and all solitary cases had a biopsy for histologic con®rmation. Autoimmune blistering diseases such as pemphigus were excluded by immuno¯uorescent study. We have analyzed for the mutations in 18 families/patients with the disease, and detected 11 different mutations in 11 families/ patients. Of the 11 families/patients, eight were sporadic and three were familial ( Table I) .
Genomic DNA was prepared from peripheral blood, and CSGE analysis and polymerase chain reaction (PCR) ampli®cation of exonic DNA was performed as described previously (Bonifas et al, 1992; Christiano et al, 1997; Hu et al, 2000) . PCR products producing abnormal CSGE patterns were directly sequenced by the dye-termination method using an ABI PRISM 310 genetic analyzer. CSGE or restriction endonuclease analysis was used to exclude the presence of identi®ed mutations in unaffected individuals in the families and in 50 patients without HHD.
RESULTS

Mutational analysis
We identi®ed mutations in ATP2C1 in 11 out of 18 Japanese HHD (JHHD) patients/families studied (Table II) . Mutations were speci®c to the affected individuals and were not detected in the unaffected individuals in the families or in the 50 control subjects without HHD. Mutations were of quite varied types: four missense, two deletion mutations + premature termination codon (PTC) formation, one insertion + PTC formation, one nonsense, one in-frame deletion, one inframe deletion + insertion, and one splice junction mutation. The skipping of exon 10 in JHHD-6 was con®rmed by reverse transcription PCR (RT-PCR) and sequencing (data not shown). Exons in which mutations were observed were 7 (one), 10 (one), 12 (two), 16 (one), 22 (one), 23 (two), and 24 (three) (the number in brackets indicates the frequency of mutations).
Genotype±phenotype comparison
The most interesting case was JHHD-4. In this family, the affected mother had generalization of HHD when she was 47 y old (which was precipitated by pseudomonas aeruginosa infection), and has been showing complete remission for at least 3 y after becoming 70. She also showed erythema and erosions at intertriginous areas from age 47 to 70. Affected ®rst and second sons have shown erythema and erosions predominantly at axillary and anogenital areas. In this family, a 2303delAC mutation of the gene leading to PTC at four amino acids downstream was identi®ed. Another interesting case was JHHD-7. In this family, the affected father showed generalized skin eruption resembling keratotic papules, which are usually observable in Darier's disease patients. On histopathologic examination of the keratotic papulles, acantholysis at suprabasal layers and scant corps ronds were observed. After retinoid therapy, this patient showed erythema that was restricted to the intertriginous areas. After discontinuation of the treatment, generalized keratotic papules have recurred so far three times. In addition, the affected son in JHHD-7 has only faint erythema at the axillar areas. In this family, a unique mutation of an in-frame three amino acid deletion plus eight amino acid insertion at exon 12 was detected in both affected father and son. The case of JHHD-6 shows relatively extensive blisters and erosions at upper back to nape areas in addition to intertriginous involvement. In this patient, a GT to GC mutation at the splice donor site of exon 10 was observed. The remaining cases have shown erythema and erosions at intertriginous areas. Intrafamilial and interfamilial variations of response to therapy with topical steroids such as chrobetasol propionate, however, have been observed (Table I) .
DISCUSSION
Spectrum of mutations In this study, we detected six mutations of ATP2C1 in six additional JHHD patients/families, and report a total of 11 different mutations including ®ve previously reported mutations. These ®ndings provide further support that HHD is caused by the mutations in ATP2C1 that codes the calcium pump at Golgi, and that there is no genetic heterogeneity even in different ethnic groups. Mutations JHHD-1 to JHHD-5 were reported previously (Hu et al, 2000) . Mutations JHHD-2 and JHHD-3 were incorrectly reported as A304T and P724 previously (Hu et al, 2000) . Mutated exons: 7 (one), 10 (one), 12 (two), 16 (one), 22 (one), 23 (two), 24 (two).
In previous reports, complete deletion of one ATP2C1 allele was detected in at least one HHD kindred [HHD-Ma in the reports of Peluso et al (1995) and Hu et al (2000) ], and 19 out of 34 mutations were of PTC causing mutations, ®ve out of 34 were of exon skipping mutations, and 10 out of 34 were of missense mutations (Hu et al, 2000; Sudbrak et al, 2000) . In our additional mutation search on six unrelated patients/families, four out of six mutations were thought to be``function-lacking'' mutations (i.e., in-frame deletion, insertion + PTC, insertion + frameshift PTC, in-frame deletion + insertion, and splice junction mutation) that alter the functionally important domains of ATP2C1. One in-frame deletion (739delI) occurred at predicted transmembrane domain 6. One in-frame deletion/insertion occurred adjacent to a predicted phosphorylation site. Splice junction mutation of exon 10 was supposed to result in lack of predicted transmembrane 3 and PTC formation 22 amino acids downstream of the missing exon 10. The remaining two were missense mutations that resulted in nonconservative amino acid substitutions at residues conserved with the rat pmr1 (Sudbrak et al, 2000) . Of these, V463G occurred at around the predicted hinge domain, and L749R occurred at predicted transmembrane 6. These ®ndings suggest that the mechanism underlying the autosomal dominant inheritance in HHD might be haplo-insuf®ciency. The mutations previously reported and those detected in this study spread throughout the ATP2C1 gene (i.e., exons 2, 3, 7, 8, 10, 11, 12, 13, 15, 16, 17, 18, 20, 21, 22, 23, 24, 26) . Mutation hot spots were not observed.
Genotype±phenotype comparison
We further compared the intrafamilial and interfamilial clinical features of the patients in conjunction with the type of mutations detected in 11 HHD patients/families. All the patients in whom missense mutations were detected have been showing common clinical features such as erythema, erosions, and scales at intertriginous areas, and have not shown any additional unique features. There were some differences in the response to topical steroid therapy and secondary infected pathogens at the affected skin sites, however ( Table I) .
The remaining three cases/families showed interesting clinical features and mutation patterns. In the case of JHHD-4, the affected mother once showed generalization precipitated by pseudomonas aeruginosa infection when she visited a hot spa at age 47. After that she showed erythema at intertriginous areas, and she showed complete remission as she got older. Of note, her occupation was a housewife. Although we have been observing this family for more than 19 y, her two affected sons have only shown skin disease at intertriginous areas. Response to the steroid ointment for each case in this family is variable, however (i.e., the effect of the strongest steroid ointment, chrobetasol propionate ointment, has been poor on the second son) ( Table I) . In this family, 2303delAC mutation of the gene leading to PTC at four amino acids downstream was identi®ed in all affected individuals. In the family JHHD-7, the affected father showed generalized skin eruption resembling Darier's disease, and showed minimal erythema at intertriginous areas after retinoid therapy. After discontinuation of the retinoid treatment, generalized keratotic papules have recurred so far three times. This condition has been lasting even after his retirement. His affected son has been showing only faint erythema at intertriginous areas. In this family, a unique mutation of in-frame three amino acid deletion plus eight amino acid insertion at exon 12 was detected. No speci®c factors to cause generalized keratotic papules such as other medical conditions, lifestyle, and profession have been reported. The remaining case of JHHD-6 showed clinical features from childhood and has been showing relatively extensive blisters and erosions at upper dorsal to occipital areas in addition to erythema at intertriginous areas. We cannot conclude that early onset and extensive blistering are speci®c to this patient, however. In this patient, GC to GC mutation at the splice donor side of exon 10 was observed.
In conclusion of our mutation and clinical study of Japanese patients with HHD, we speculate that clinical phenotype might not relate to the types of mutation in ATP2C1. Clinical phenotype might simply be in¯uenced by other intrinsic and extrinsic factors such as expression levels of ATP2C1 in each patient, ultraviolet irradiation, high environmental temperature, minor mechanical stimuli in daily life, and the presence of pathogens, etc. To test these possibilities, we are now evaluating the effect of ultraviolet irradiation or switching extracellular calcium concentration on the expression of ATP2C1 in cultured normal human epidermal keratinocytes by quantitative RT-PCR, and also we are examining the expression levels of ATP2C1 in multiple different skin sites from a normal individual. These examinations will provide much information for the understanding of the intrafamilial and interfamilial clinical phenotype variation of the patients, as well as the mechanisms underlying the autosomal dominant inheritance of this disease.
